Sökning: WFRF:(Mitroulis Ioannis) >
Complement C3 inhib...
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101
-
- Skendros, Panagiotis (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Germanidis, Georgios (författare)
- Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Thessaloniki, Greece.;Aristotle Univ Thessaloniki, Sch Med, Special Unit Biomed Res & Educ SUBRE, Basic & Translat Res Unit, Thessaloniki, Greece.
-
- Mastellos, Dimitrios C. (författare)
- Natl Ctr Sci Res Demokritos, Athens, Greece.
-
visa fler...
-
- Antoniadou, Christina (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Gavriilidis, Efstratios (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Kalopitas, Georgios (författare)
- Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Thessaloniki, Greece.;Aristotle Univ Thessaloniki, Sch Med, Special Unit Biomed Res & Educ SUBRE, Basic & Translat Res Unit, Thessaloniki, Greece.
-
- Samakidou, Anna (författare)
- Gen Univ Hosp Larissa, Natl & European Expertise Ctr Greece Autoimmune L, Dept Med, Larisa, Greece.;Gen Univ Hosp Larissa, Natl & European Expertise Ctr Greece Autoimmune L, Res Lab Internal Med, Larisa, Greece.
-
- Liontos, Angelos (författare)
- Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Internal Med, Ioannina, Greece.
-
- Chrysanthopoulou, Akrivi (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Ntinopoulou, Maria (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Kogias, Dionysios (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Karanika, Ioanna (författare)
- Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Thessaloniki, Greece.;Aristotle Univ Thessaloniki, Sch Med, Special Unit Biomed Res & Educ SUBRE, Basic & Translat Res Unit, Thessaloniki, Greece.
-
- Smyrlis, Andreas (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Cepaityte, Dainora (författare)
- Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Thessaloniki, Greece.;Aristotle Univ Thessaloniki, Sch Med, Special Unit Biomed Res & Educ SUBRE, Basic & Translat Res Unit, Thessaloniki, Greece.
-
- Fotiadou, Iliana (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Zioga, Nikoleta (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Mitroulis, Ioannis (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Gatselis, Nikolaos K. (författare)
- Gen Univ Hosp Larissa, Natl & European Expertise Ctr Greece Autoimmune L, Dept Med, Larisa, Greece.;Gen Univ Hosp Larissa, Natl & European Expertise Ctr Greece Autoimmune L, Res Lab Internal Med, Larisa, Greece.
-
- Papagoras, Charalampos (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Metallidis, Simeon (författare)
- Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Thessaloniki, Greece.;Aristotle Univ Thessaloniki, Sch Med, Special Unit Biomed Res & Educ SUBRE, Basic & Translat Res Unit, Thessaloniki, Greece.
-
- Milionis, Haralampos (författare)
- Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Internal Med, Ioannina, Greece.
-
- Dalekos, George N. (författare)
- Gen Univ Hosp Larissa, Natl & European Expertise Ctr Greece Autoimmune L, Dept Med, Larisa, Greece.;Gen Univ Hosp Larissa, Natl & European Expertise Ctr Greece Autoimmune L, Res Lab Internal Med, Larisa, Greece.
-
- Willems, Loek (författare)
- Hycult Biotechnol, R&D Dept, Uden, Netherlands.
-
- Persson, Barbro (författare)
- Uppsala universitet,Vaskulärbiologi
-
- Manivel, Vivek Anand (författare)
- Uppsala universitet,Vaskulärbiologi
-
- Nilsson, Bo (författare)
- Uppsala universitet,Vaskulärbiologi
-
- Connolly, E. Sander (författare)
- Columbia Univ, Dept Neurol Surg, New York, NY USA.
-
- Iacobelli, Simona (författare)
- Univ Roma Tor Vergata, Dept Biol, Rome, Italy.
-
- Papadopoulos, Vasileios (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Calado, Rodrigo T. (författare)
- Univ Sao Paulo, Sch Med, Dept Med Imaging Hematol & Oncol, Ribeirao Preto, Brazil.
-
- Huber-Lang, Markus (författare)
- Ulm Univ Hosp, Inst Clin & Expt Trauma Immunol, Ulm, Germany.
-
- Risitano, Antonio M. (författare)
- AORN Moscati Avellino, Avellino, Italy.;Federico II Univ Naples, Naples, Italy.
-
- Yancopoulou, Despina (författare)
- Amyndas Pharmaceut, Glifadha, Greece.
-
- Ritis, Konstantinos (författare)
- Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece.
-
- Lambris, John D. (författare)
- Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
-
visa färre...
-
Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece;Democritus Univ Thrace, Univ Hosp Alexandroupolis, Lab Mol Hematol, Alexandroupolis, Greece. Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Thessaloniki, Greece.;Aristotle Univ Thessaloniki, Sch Med, Special Unit Biomed Res & Educ SUBRE, Basic & Translat Res Unit, Thessaloniki, Greece. (creator_code:org_t)
- American Association for the Advancement of Science (AAAS), 2022
- 2022
- Engelska.
-
Ingår i: Science Advances. - : American Association for the Advancement of Science (AAAS). - 2375-2548. ; 8:33
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Complement C3 activation contributes to COVID-19 pathology, and C3 targeting has emerged as a promising therapeutic strategy. We provide interim data from ITHACA, the first randomized trial evaluating a C3 inhibitor, AMY-101, in severe COVID-19 (PaO2/FiO2 <= 300 mmHg). Patients received AMY-101 (n = 16) or placebo (n = 15) in addition to standard of care. AMY-101 was safe and well tolerated. Compared to placebo (8 of 15, 53.3%), a higher, albeit nonsignificant, proportion of AMY-101-treated patients (13 of 16, 81.3%) were free of supplemental oxygen at day 14. Three nonresponders and two placebo-treated patients succumbed to disease-related complications. AMY-101 significantly reduced CRP and ferritin and restrained thrombin and NET generation. Complete and sustained C3 inhibition was observed in all responders. Residual C3 activity in the three nonresponders suggested the presence of a convertase-independent C3 activation pathway overriding the drug's inhibitory activity. These findings support the design of larger trials exploring the potential of C3-based inhibition in COVID-19 or other complement-mediated diseases.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Skendros, Panagi ...
-
Germanidis, Geor ...
-
Mastellos, Dimit ...
-
Antoniadou, Chri ...
-
Gavriilidis, Efs ...
-
Kalopitas, Georg ...
-
visa fler...
-
Samakidou, Anna
-
Liontos, Angelos
-
Chrysanthopoulou ...
-
Ntinopoulou, Mar ...
-
Kogias, Dionysio ...
-
Karanika, Ioanna
-
Smyrlis, Andreas
-
Cepaityte, Daino ...
-
Fotiadou, Iliana
-
Zioga, Nikoleta
-
Mitroulis, Ioann ...
-
Gatselis, Nikola ...
-
Papagoras, Chara ...
-
Metallidis, Sime ...
-
Milionis, Harala ...
-
Dalekos, George ...
-
Willems, Loek
-
Persson, Barbro
-
Manivel, Vivek A ...
-
Nilsson, Bo
-
Connolly, E. San ...
-
Iacobelli, Simon ...
-
Papadopoulos, Va ...
-
Calado, Rodrigo ...
-
Huber-Lang, Mark ...
-
Risitano, Antoni ...
-
Yancopoulou, Des ...
-
Ritis, Konstanti ...
-
Lambris, John D.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Science Advances
- Av lärosätet
-
Uppsala universitet